We are looking for individuals who have Alzheimer’s Disease for a study of an investigational medication designed to slow the progression of Alzheimer’s disease. To be eligible, participants must:
- Be 55 to 80 years of age
- Have been diagnosed with Alzheimer’s disease
- Have an MRI or CT scan that was performed after the Alzheimer’s disease diagnosis
- Have a study partner who can attend appointments
Eligible participants will receive study-related care, monitoring and investigational medication or placebo. Compensation for time and travel may be available to patient and caregiver.
For details, call Meridien Research at 407-644-1165!